Clinical Trial Update: Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (ACROBAT) investigates the feasibility of allogeneic stem cell transplantation in patients with higher-risk myelodysplastic syndromes; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: High-risk MDS | Phase 3 | Status: RECRUITING